Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.990
+0.006 (0.62%)
At close: Nov 20, 2024, 4:00 PM
1.040
+0.050 (5.05%)
After-hours: Nov 20, 2024, 6:49 PM EST
Citius Oncology Statistics
Total Valuation
CTOR has a market cap or net worth of $70.59 million.
Market Cap | 70.59M |
Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, November 29, 2024, before market open.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CTOR has 71.30 million shares outstanding.
Current Share Class | 71.30M |
Shares Outstanding | 71.30M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.07% |
Float | 5.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.92 |
P/TBV Ratio | 4.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
Current Ratio | 0.32 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -85.28% and return on invested capital (ROIC) is -51.73%.
Return on Equity (ROE) | -85.28% |
Return on Assets (ROA) | -24.23% |
Return on Capital (ROIC) | -51.73% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CTOR has paid $576,000 in taxes.
Income Tax | 576,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.93% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -90.93% |
50-Day Moving Average | 1.26 |
200-Day Moving Average | 8.59 |
Relative Strength Index (RSI) | 36.47 |
Average Volume (20 Days) | 83,988 |
Short Selling Information
The latest short interest is 39,417, so 0.06% of the outstanding shares have been sold short.
Short Interest | 39,417 |
Short Previous Month | 10,597 |
Short % of Shares Out | 0.06% |
Short % of Float | 0.75% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -18.95M |
Pretax Income | n/a |
Net Income | -19.52M |
EBITDA | n/a |
EBIT | -18.95M |
Earnings Per Share (EPS) | -$0.29 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | 17.03M |
Book Value Per Share | 0.25 |
Working Capital | -21.39M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CTOR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -27.66% |
FCF Yield | n/a |
Analyst Forecast
The average price target for CTOR is $6.00, which is 506.06% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.00 |
Price Target Difference | 506.06% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |